Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: Distinct patterns and associated risk of malignancy

Cancer Cytopathology

Volumn 119, Issue 5, 2011, Pages 322-327

  Renshaw, Andrew A ^a  

^a BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

Atypia; Cytopathology; Fine needle aspiration; Subcategory; Thyroid

Indexed keywords

ARTICLE; ATYPICAL CELLS OF UNDETERMINED SIGNIFICANCE; CANCER RISK; DISEASE CLASSIFICATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOCYTOMA; PRECANCER; PRIORITY JOURNAL; THYROID FINE NEEDLE ASPIRATION; THYROID FOLLICLE; THYROID GLAND; THYROID PAPILLARY CARCINOMA; ADENOCARCINOMA; ATROPHY; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; NEEDLE BIOPSY; PAPILLARY CARCINOMA; PATHOLOGY; RISK FACTOR; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ATROPHY; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; HUMANS; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS;

EID: 83455204123     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20154     Document Type: Article

References (16)

1. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. New York: Springer; 2010.
2. Renshaw AA, Wang E, Wilbur D, Hughes JH, Haja J, Henry MR. Interobserver agreement on microfollicles in thyroid fine-needle aspirates. Arch Pathol Lab Med. 2006;130:148-152.
3. Abele JS, Levine RA. Diagnostic criteria and risk-Adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010;118:415-422.
4. Renshaw AA. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassifiedCancer Cytopathol. 2010;118:186-189.
5. Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol. 2002;118:208-210.
6. Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980-1986. Acta Cytol. 1987;31:587-590.
7. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner Jr. Long term follow up of patients with benign thyroid fine needle aspiration cytologic diagnoses. Surgery. 1989;106:980-986.
8. Renshaw A. An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates. Cancer Cytopathol. 2010;118:190-195.
9. Renshaw AA. Erratum: Should "atypical follicular cells" in thyroid fine needle aspirates be subclassifiedCancer Cytopathol. 2010;118:303.
10. Renshaw AA. Erratum: An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates. Cancer Cytopathol. 2010;118:303.
11. Wu HH, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262-266.
12. Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for thyroid fine needle aspirates: defining more consistent and specific cytologic criteria. Cancer Cytopathol. 2002;96:261-266.
13. Roh MH, Jo VY, Stelow EB, et al. The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, Hurthle cell type" in patients with Hashimoto thyroiditis. Am J Clin Pathol. 2011;135:139-145.
14. Renshaw AA. Does a repeated benign aspirate change the risk of malignancy after an initial atypical thyroid fine-needle aspirationAm J Clin Pathol. 2010;134:788-792.
15. Marchevsky AM, Walts AE, Bose S, et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol. 2010;38: 252-259.
16. Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38:731-739.